Literature DB >> 25224530

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Zhifeng Mao1, Zhengqi Lu1, Xueqiang Hu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25224530     DOI： 10.1212/WNL.0000000000000830

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Recurrent Longitudinally Extensive Myelitis and Aquaporin-4 Seronegativity - The Expanding Spectrum of Neuromyelitis Optica.

Authors:  Ravi Anadure; Coimbatore Sivasubramanian Narayanan; Govindaraj Varadraj
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 2.  Aquaporin-4 autoimmunity.

Authors:  Anastasia Zekeridou; Vanda A Lennon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-05-21

3.  Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination.

Authors:  Richard Heekin; Chetan Gandhy; Derrick Robertson
Journal:  Case Rep Neurol       Date:  2015-04-11

4.  Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.

Authors:  Liuyu Lin; Yuqing Wu; Hailun Hang; Jie Lu; Yuanliang Ding
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.